[1
]
From Memorial Sloan Kettering Cancer Center, New York (R.J.M.), and Roswell Park Cancer
Institute, Buffalo (S.G.) - both in New York; Institut Gustave Roussy, Villejuif (B.E.),
and Bordeaux University Hospital, Hôpital Saint André, Bordeaux (A.R.) - both in France;
Beth Israel Deaconess Medical Center (D.F.M.) and Dana-Farber Cancer Institute, Brigham
and Women's Hospital, and Harvard Medical School (T.K.C.) - all in Boston; Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center, Baltimore (H.J.H.); Stanford Cancer Institute,
Stanford, CA (S.S.); University of Washington and Fred Hutchinson Cancer Research
Center, Seattle (S.S.T.); Vanderbilt University Medical Center, Nashville (J.A.S.);
Fondazione Istituto Nazionale Tumori, Milan (G.P.); Fox Chase Cancer Center, Philadelphia
(E.R.P.); Hospital Universitario 12 De Octubre, Madrid (D.C.); Westmead Hospital and
Macquarie University, Sydney (H.G.); Aarhus University Hospital, Aarhus, Denmark (F.D.);
Helsinki University Central Hospital and University of Helsinki, Helsinki (P.B.);
South West Wales Cancer Institute and Swansea University College of Medicine, Swansea
(J.W.), and Royal Marsden Hospital, London (J.L.) - both in the United Kingdom; University
Hospital Essen of University of Duisburg-Essen, Germany (T.C.G.); Chiba Cancer Center,
Chiba (T.U.), and Niigata University, Niigata (Y.T.) - both in Japan; Hospital Sao
Jose, Beneficencia Portuguesa de São Paulo, São Paulo (F.A.S.); British Columbia Cancer
Agency, Vancouver, BC, Canada (C.K.); Bristol-Myers Squibb, Lawrenceville (J.S.S.,
I.M.W.) and Hopewell (L.-A.X.) - both in New Jersey; and M.D. Anderson Cancer Center,
University of Texas, Houston (P.S.).